CELC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Celcuity Inc (CELC) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks immediate positive momentum, as technical indicators are neutral to bearish, and there are no recent Intellectia Proprietary Trading Signals to suggest a compelling entry point. While analysts maintain a generally positive long-term outlook, recent price target reductions and lack of significant catalysts in the short term make it prudent to hold off on buying.
The MACD histogram is negative (-1.03) and contracting, suggesting bearish momentum. RSI is at 28.55, which is neutral but close to oversold territory. Moving averages are converging, indicating indecision in price direction. Key support is at $83.914, with resistance at $94.165. The stock is trading below the pivot level ($89.04), which is a bearish signal.
Analysts maintain a Buy or Overweight rating, citing long-term potential for gedatolisib in the VIKTORIA-1 study. Positive updates on gedatolisib's efficacy and potential launch in PI3Kwt patients could drive future growth.
Recent price target reductions from multiple analysts reflect concerns over the lack of additive efficacy in the gedatolisib triplet versus doublet. Stock weakness is driven by competitive risks and modest mPFS results. Technical indicators and options data suggest bearish sentiment in the short term.
No financial data available for the latest quarter. Unable to assess growth trends.
Analysts have lowered price targets recently but maintain a Buy or Overweight rating. The average price target remains significantly higher than the current price, reflecting long-term optimism despite short-term concerns.
